Related Experiment Videos
[Treatment of priapism with phenylephrine]
G Azócar Hidalgo1, R Van Cauwelaert, O Castillo Cádiz
1Unidad de Urología, Clínica de Santa María, Santiago, Chile.
Archivos Espanoles De Urologia
|October 1, 1994
Summary
Intracavernous phenylephrine effectively treats pathological erection, achieving detumescence rapidly with a 93.1% success rate. This method offers a safe alternative to more aggressive treatments for prolonged erections.
Area of Science:
- Urology
- Pharmacology
Background:
- Pathological erection, or priapism, presents a significant clinical challenge.
- Various treatment modalities exist, but often involve invasive procedures or carry risks.
Purpose of the Study:
- To evaluate the efficacy and safety of intracavernous phenylephrine for treating pathological erection.
Main Methods:
- Intracavernous phenylephrine injections were administered to patients experiencing pathological erection over a 3-year period.
Main Results:
- A high success rate of 93.1% was achieved, with detumescence occurring rapidly between 30 seconds and 15 minutes.
- No complications were reported by patients.
- Patients experienced no adverse effects on their sexual activity.
Conclusions:
- Intracavernous phenylephrine is a highly effective and safe treatment for pathological erection.
- It offers a less invasive option compared to other therapeutic maneuvers.
- This treatment should be considered prior to implementing more aggressive interventions.